Benitec Biopharma
BNTC
$8.87
Share price
7.89%
Change (1 day)
4,334.30%
Change (1 year)
Benitec Biopharma (BNTC) - Cash on Hand
Cash on Hand as of December 2023 : $20.37 M
According to Benitec Biopharma
's latest financial reports the company has $20.37 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Benitec Biopharma - Cash on Hand chart (from 2020 to 2019)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $2.47 M | -39.02% |
| 2022-06-30 | $4.06 M | -79.45% |
| 2021-06-30 | $19.76 M | 101.7% |
| 2020-06-30 | $9.8 M | -11.22% |
| 2019-06-30 | $11.03 M | 26.04% |
| 2018-06-30 | $8.75 M | -14.64% |
| 2017-06-30 | $10.26 M | 0.75% |
| 2016-06-30 | $10.18 M | -20.56% |
| 2015-06-30 | $12.82 M | -33.62% |
| 2014-06-30 | $19.31 M | -26.06% |
| 2013-06-30 | $26.12 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.35% | Bahamas |
 NRC Health
NRC | $6.65 M | -67.35% | 🇺🇸 USA |